Cours YM BioSciences Inc.

Actions

29/02/12	YM Biosciences : Raises US$80.5 Million from Public Offering
24/02/12	YM Biosciences : Prices $70 Million Public Offering of Common Shares
23/02/12	YM Biosciences : Announces Proposed Public Offering of Common Shares
09/02/12	YM Biosciences : Reports Operational and Financial Results for the Second Quarter of Fiscal 2012
12/12/11	YM Biosciences : Reports Updated Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at ASH 2011

Ajouter à une liste 0 sélectionné Pour utiliser cette fonction vous devez être client ou membre Connexion Inscription	Varia.	Varia. 5j.	Varia. 1an	Varia. 3ans	Capi.($)
YM BIOSCIENCES INC.	-.--%	+0,34%	-	-	0
LONZA GROUP AG	-0,79%	-1,36%	+2,32%	+14,20%	49,24 Md
REVOLUTION MEDICINES, INC.	-1,59%	+2,12%	+460,02%	+573,56%	43,3 Md
BEONE MEDICINES AG	-0,85%	+7,95%	+15,77%	+80,09%	40,48 Md
IQVIA HOLDINGS INC.	-0,08%	+3,91%	+26,96%	+9,86%	39,75 Md
CELLTRION, INC.	0,00%	+3,59%	+20,51%	+48,00%	32,67 Md
ASCENDIS PHARMA A/S	-3,61%	-1,45%	-	-	16,23 Md
MEDPACE HOLDINGS, INC.	-2,52%	-0,52%	+24,35%	+118,05%	16,24 Md
EUROFINS SCIENTIFIC SE	+0,86%	+1,29%	+4,71%	+22,62%	14,04 Md
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1,09%	+5,94%	+81,46%	+31,15%	13,43 Md
Moyenne	-0,97%	+2,30%	+79,51%	+112,19%	29,49 Md
Moyenne pondérée par Capi.	-0,93%	+2,71%	+96,20%	+134,01%